On July 31, 2023, TRxADE HEALTH Inc. announced that in connection with the Merger, the Board appointed Candice Beaumont as a director of the Board, effective as of July 31, 2023, to serve until the Company?s 2024 annual meeting of stockholders or until his successor is duly elected and qualified, or until her earlier death, resignation or removal. Ms. Beaumont is the Executive Director of Superlatus. She has more than two decades of executive experience in finance, banking, M&A and investments.

She currently serves as chairperson of Salsano Group, a Panama-based family office and holding company with investments in over one hundred (100) companies across multiple sectors, including global real estate, luxury goods, consumer, technology, and media. Ms. Beaumont is also Chief Investment Officer at L Investments, a family office that is invested in a broad portfolio of public and private equity. Previously, as a banker at Lazard Frères, Ms. Beaumont executed more than $20 billion in merger and acquisition advisory engagements.

She also served as the private equity principal at Argonaut Capital, a global macro hedge fund. She began her career in corporate finance at Merrill Lynch. Ms. Beaumont is a member of the board of directors of several SPACs, including Clean Earth Acquisition Corp.

She is also serves as an advisor to Athena Technology Acquisition Corp. and Springwater Situations Corp. Ms. Beaumont is an advisory board member of the Family Office Association, a global membership organization exclusive to single family offices and families of significant wealth.

She is a NYU Stern Family Office Council member and serves on its steering committee. She also serves on the steering committee of the Yale University School of Management College of Family Offices, as well as the Princeton University Council of Family Offices and Endowments.